相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques
R. Karl Malcolm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5
Zahra F. Parker et al.
JOURNAL OF VIROLOGY (2013)
Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design
Li-Hua Ping et al.
JOURNAL OF VIROLOGY (2013)
Constitutively Active CCR5 Chemokine Receptors Differ in Mediating HIV Envelope-dependent Fusion
Alex de Voux et al.
PLOS ONE (2013)
Genetically Encoded Photo-cross-linkers Map the Binding Site of an Allosteric Drug on a G Protein-Coupled Receptor
Amy Grunbeck et al.
ACS CHEMICAL BIOLOGY (2012)
Sustained Release of the CCR5 Inhibitors CMPD167 and Maraviroc from Vaginal Rings in Rhesus Macaques
R. Karl Malcolm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A Dichotomy in Cortical Actin and Chemotactic Actin Activity between Human Memory and Naive T Cells Contributes to Their Differential Susceptibility to HIV-1 Infection
Weifeng Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc
Reem Berro et al.
VIROLOGY (2012)
New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
Javier Garcia-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Fabien M. Decaillot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors
Reem Berro et al.
JOURNAL OF VIROLOGY (2011)
HIV-1 entry inhibition by small-molecule CCR5 antagonists: A combined molecular modeling and mutant study using a high-throughput assay
Jean Labrecque et al.
VIROLOGY (2011)
Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX)
Supachoke Mangmool et al.
TOXINS (2011)
HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry
John C. Tilton et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV-1 Entry via the CCR5 Co-Receptor
Ronald S. Veazey et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes
Shixin Ye et al.
NATURE (2010)
Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step
Brooke Harmon et al.
PLOS PATHOGENS (2010)
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
Cleo G. Anastassopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Xiao Jie Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A piece de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
John P. Moore et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Chemokine Coreceptor Signaling in HIV-1 Infection and Pathogenesis
Yuntao Wu et al.
PLOS PATHOGENS (2009)
Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
Reem Berro et al.
PLOS PATHOGENS (2009)
Gαi protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription
Clement Mettling et al.
AIDS (2008)
HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells
Alyson Yoder et al.
CELL (2008)
CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity
Clara Moyano Cardaba et al.
CELLULAR SIGNALLING (2008)
Induction of the Gαq signaling cascade by the human immunodeficiency virus envelope is required for virus entry
Brooke Harmon et al.
JOURNAL OF VIROLOGY (2008)
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
Robert A. Ogert et al.
VIROLOGY (2008)
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Rama Kondru et al.
MOLECULAR PHARMACOLOGY (2008)
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
Chih-chin Huang et al.
SCIENCE (2007)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
Interaction of small molecule inhibitors of HIV-1 entry with CCR5
Christoph Seibert et al.
VIROLOGY (2006)
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor
RS Veazey et al.
NATURE MEDICINE (2005)
Structure of a V3-containing HIV-1 gp120 core
CC Huang et al.
SCIENCE (2005)
Generation and properties of a human immunodeficiency virus type I isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)
AJ Marozsan et al.
VIROLOGY (2005)
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
B Lagane et al.
MOLECULAR PHARMACOLOGY (2005)
Roles of substrate availability and infection of restina and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection
ZQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors
E Billick et al.
JOURNAL OF VIROLOGY (2004)
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor
SE Kuhmann et al.
JOURNAL OF VIROLOGY (2004)
Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2
DA Arias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry
F Tsamis et al.
JOURNAL OF VIROLOGY (2003)
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type I isolates
A Amara et al.
JOURNAL OF VIROLOGY (2003)
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3
C Govaerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction
AE Brady et al.
CELLULAR SIGNALLING (2002)
Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES
AJ Marozsan et al.
JOURNAL OF VIROLOGY (2001)
The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation
C Govaerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
T Dragic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
